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Laser irradiation therapy on cancer cells is a promising alternative in providing a non-invasive treatment of breast cancer 
that has a possibility to inhibit cancerous cells selectively without damaging surrounding healthy tissues. This present study 
aimed to evaluate the effect of the low-level green laser of 532 nm wavelength with various laser power and irradiation time 
on MCF-7 cancer cell lines. In this work, the MCF-7 cells were seeded to a rate of fifty thousand cells/well in 96-well plate 
and incubated for 24 h. The cells were then irradiated with the green laser at different power from 0.002 to 0.1 W at 60 s, 
540 s, and 900 s duration. The cell viability of the cells was measured by using Alamar Blue assay. From result, the laser 
irradiation on the cells was able to produce 25-40% inhibition of cell proliferation whereby the untreated cells exhibited a 
93% cell viability. It was revealed that high power with longer exposure time increased cell bio-inhibition. Thus, this work 
using low-power green laser irradiation on cells demonstrated a significant effect on cells and was also demonstrated a 
promising non-invasive approach that can be used alone or in combination with several other therapies in cancer treatment. 
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Cancer is one of the major health issues and it is the 
second leading cause of death globally with 9.6 
million deaths in 2018 that expected to increase up to 
12 million in 2030 according to a press release by 
World Health Organization (WHO)
1
. The WHO press 
release also revealed the female breast cancer was the 
fifth leading cause of death amounting to 627000 
deaths (6.6% of total deaths). The burden of cancer 
diseases on human life remains to be disastrous 
despite significant breakthroughs in our medical 
technology and cancer research attempts. Typical 
cancer treatments such as surgery, radiotherapy, and 
chemotherapy are usually performed to treat cancer 
patients offered a little contribution to the survival 
and often followed by serious long-term side effects 
as these treatments also induce damage on normal 
cells. However, applications which are commonly 
used in physics, such as laser, can help to develop an 
effective strategy for a cure. The application of laser 
devices in oncology is a promising alternative in 
providing a non-invasive therapy of breast cancer. 
The word of ―LASER‖ is an acronym for light 
amplification by stimulated emission of radiation. In 
1960, Theodore H. Maiman developed the first 




Interaction between laser irradiation and biological 
tissues has been an area of great interest
3
. Lasers are 
classified as hard and soft tissue lasers based on the 
type of laser–tissue interaction and not on the type of 
tissue exposed
4
. Photons emitted by the laser can 
either be absorbed or scattered by tissue whereby the 
scattered photons will eventually be absorbed or 
escape from tissue via diffuse reflection
5
. Meanwhile, 
the absorbed photons interact with photoreceptors or 
chromophores located within the tissue resulting in 
energy- boosting of the electrons in molecular orbitals 
and the hot electrons emit photoelectrons by losing its 
energy
6
. After that, the emitted photoelectrons transfer 
a photon or electron to form a free radical anion or 
radical cation and these radicals may further react 
with oxygen to produce Reactive Oxygen Species 
(ROS) that can cause significant toxicity leading to 











Interestingly, the laser in the medical application 
have two general categories which are high intensity 
and low intensity. Each of these categories has very 
different therapeutic properties in their designs and 
applications. High power lasers cut tissue while low-
power lasers stimulate various tissues and help the 
cells to function
8
. However, high doses of laser have 
certain disadvantages, and to overcome these matters, 
extensive research is going on with low-level laser 
therapy (LLLT) as this therapy has a stimulatory 
effect on cells at a low dosage and a suppressive 
effect at high dosage. LLLT involves an application 
of a light source (laser) that is set at low power known 
as ―cold laser‖ due to its low thermal effect. In 
general, the power densities used for LLLT are lower 
than those needed to produce heating in tissue that 
depends on wavelength and tissue type
3
. The 
hyperthermia effect due to the laser thermal energy 
occurs when the heat is used to increase the body 
temperature from a normal 37°C to the temperature 
ranging from 41 to 45°C
9
. Therefore, the critical 
temperature at which cancer cells can be killed while 
normal tissues remain alive is 45°C as the heat 
reduced by blood flow protects the healthy tissue 
from overheating
9,10
. In spite of that, this laser thermal 
therapy with the aim to produce significant tissue 
destruction heating also have the risk to lead the cell 
death of normal tissues even it has positive effects on 




LLLT has shown remarkable results in a wide 
range of medical technologies due to its wavelength 
and biphasic dose- effect at a cellular level
2
. LLLT 
has been thoroughly studied to understand its action 
mechanisms on the metabolism of benign cells
12
. It is 
reported that LLLT could improve the process of 
wound healing and also has stimulating effects on 
bone cells and can hasten the repair process of the 
bone
8
. Unfortunately, LLLT is also known to increase 
cell proliferation, leading to the stimulation of 
undesired risk of cancer cell growth
13
. Laser light may 
induce the number of genomically altered cells with 
greater proliferative activity in malignant cells, 
indirectly accelerating the mutations during the 
natural carcinogenesis process
14
. Due to many 
variables in the use of laser light source and treatment 
procedures, previous studies always came out with 
different conclusions which difficult to the clinical 
team to select the optimum parameters. Thus, 
researchers and therapists have questioned the clinical 
benefits of laser therapy caused by divergent results  
in the literature due to lack of methodological 
standardisation in studies as well as by its clinical 
applicability
15
. In addition, the wavelengths, dosage 
schedules, and appropriate conditions of laser 
irradiation are also not well established.  
The first study used the LLLT for cancer study was 
done by Mester and his team. Their aim of the 
research was to study the effect of LLLT on the 
shaved dorsal skin of mice. Despite LLLT did not 
cause any tumours development, they observed a 
higher rate of hair development and better wound 
healing after the irradiation. This was the first sign 
that low-level laser light could have its own useful 
medical applications
16
. However, a study found that 
after 635 and 670 nm irradiation on H.Ep.2 cells 
could significantly increase the proliferation of 
laryngeal cancer cells
17
. Another study observed the 
percentage of lung cancer cell proliferation were 
higher in the treated group by using Nd:YAG laser 
compared to the control groups and concluded that 
LLLT promote cancer cell proliferation depending on 
the power of the laser and the number of treatments
18
. 
Their study proved this therapy using Nd:YAG laser 
does not inhibit lung cancer cell proliferation. Their 
results can also be supported by previous research in 
2015, the human leukemic cells that were irradiated 
(810 nm) with a different dose, 20 J/cm
2
 (high dose) 
showed a significant increase in cell proliferation after 
two exposures but there were no changes in the 
growth rate of cells treated with lower doses at  
5 J/cm
2
 and 10 J/cm
2 19
. In the same year, the breast 
cancer line of MDA-MB-231 cell viability increased 
after being treated by laser with 248 nm but slightly 
decreased after irradiated with both 1064 and 532 nm 
lasers were found in the study by
20
. Because LLLT 
has been shown to stimulate the development of 
cancer cells and may also enhance the aggressiveness 
of some cancer cells, some researchers have claimed 
that LLLT may be contraindicated in clinical use in 
cancer patients
21
. Fortunately, it was found that LLLT 
was very effective at minimizing many distressing 




In the meantime, the exact action mechanism of 
LLLT are not well understood and several theories 
exist. As stated by
23
, most of the study and the best 
understood in the mechanism of this therapy being 
that of cytochrome-c oxidase (Complex IV) in the 
cellular mitochondrial respiratory chain. Complex IV 




appears to be a chromophore or photoreceptor that 
absorbs energy from photons moving on wavelengths 
in the near- infrared spectrum which accelerates 
electron transfer rate
8
. The more photons being 
absorbed by cytochrome c oxidase, the more oxidized 
state cytochrome c oxidase will be. On the other hand, 
since cytochrome c oxidase is modulated by the 
LLLT, the production of ROS will then be 
activated
24,25
. The photon absorption by photoreceptor 
can also transfer the energy to other molecules that 
leading photochemical reactions in surrounding tissue 
and give rise to observable biological impacts
26
. The 
effectiveness of laser therapy is characterized by a 
biphasic dose response curve. The biphasic dose-
response curve or Arndt – Schulz curve is a crucial 
part of LLLT. This principle specifies that optimum 
parameters provide an advantage to the specific 
disease, and if these parameters are significantly 
surpassed, the advantages will disappear and may 
even result in harmful outcomes when the dose is 
extraordinarily high
27
. In an attempt to better 
understand the effect of laser therapy on cancer cells, 
this work investigated the effect of low-level green 
laser 532 nm on breast carcinoma cell line, MCF-7 
cell and to find the optimum laser dose for 
appreciable cell inhibition.  
 
Materials and Methods 
Cell Culture 
Human breast cancer cell line, MCF-7, was used in 
this research. MCF-7 cell line was grown in RPMI 1640 
medium with Stable Glutamine (Capricorn Scientific 
GmbH) supplemented with 10% heat-inactivated Fetal 
Bovine Serum, FBS (Capricorn Scientific GmbH) and 
1% penicillin-streptomycin (Merck Millipore). The cells 
were maintained in an incubator at 37°C in an 
atmosphere of 5% CO2 in air at a relative humidity of 
80%. At 80 to 90% confluence, cells were harvested by 
using 1 mL trypsin and were subcultured into 75 cm
2
 
flasks and 96-well plates according to experiments. 
Cells were allowed to attach to the surface for 24 h 
prior to treatment.  
 
Laser system 
The experiments were conducted with a low-power 
green laser DPSS (Diode-Pumped Solid-State) laser 
system in Medical Physics Laboratory in School of 
Physics, Universiti Sains Malaysia, that emitted laser 
rays at 532 nm and the laser was set at several power 
outputs up to 0.1 W. The Table 1 shows the list of 
different power, time exposure and dose energy of 
green laser used in the treatment. Dose was calculated 
following the equation: Irradiance (J/cm
2





. This laser was calibrated 
before the irradiation procedure.  
 
Treatment 
Laser irradiation on MCF-7 cells with different 
dose energy was conducted in sterile culture hood to 
avoid any contamination. This test also have 
performed in dark surrounding to eliminate influences 
from other light source
14
. In 96-well plates, the cells 
were seeded at a density of 5 × 10
4
 cells/well with 
complete media and incubated for 24 h before 
irradiated with the green laser system. The cells were 
irradiated by laser beam with a 5 mm diameter  
at different power and time exposure as shown in 
(Table 1). The distance between each well and laser 
system was 1 cm. The unused wells were covered up 
with media without cells to prevent unintentional light 





Table 1 — List of different power, time exposure and dose energy 
for 532 nm laser irradiation used in this experiment 
Power (W) Exposure time (s) Dose (J/cm2) 
0.002 60 0.24 
540 2.16 
900 3.60 
0.02 60 2.40 
540 21.60 
900 36.00 
0.06 60 7.20 
540 64.80 
900 108.00 






Fig. 1 — 96-well plate template for laser irradiation therapy.  
The black color indicated wells filled with the media only 
(without cells) 












 columns of these plates are filled 
with 100 µL of media as indicated in black colour as 
shown in (Fig. 1). The experiments were carried out 
in triplicates for each dose. After laser irradiation, the 
treated cells were incubated again at 37°C and 5% 
CO2 in a humidified atmosphere incubator for 24 h. 
The untreated and treated cells were observed under 
Phase Contrast Inverted Microscope (Olympus). 
 
Cell viability test 
After 24 h incubation, cytotoxicity of irradiated 
cells was performed with Alamar Blue Reagent to 
check the cell viability according to the Bio-Rad AbD 
Serotec protocol. This assay was selected because  
it is not toxic to cells and does not necessitate killing 
cells during the experiment. Furthermore, this assay 
also does not change the viability of the cell, unlike 
that which happens by trypan blue exclusion. The 
medium from the wells was removed carefully  
after incubation. Each well was rinsed with Phosphate 
Buffered Saline (PBS) three times and 10% of the 
Alamar Blue solution with 90 µL of fresh media  
were added to each well. The cells then were 
incubated for another 6 h at 37°C. The absorbance 
value at 570 nm and 600 nm were measured by a 
microplate reader (Model BioTek Power Wave 
XS).The assays were carried out five times for each 
dose with the same methodology and condition to 
investigate either there were major or minor changes 
in the results.  
 
Statistical analysis 
The values were expressed as the mean ± SD. 
Statistical analysis was performed using ANOVA. 
Student’s t-test were used to determine the significant 
difference between groups. Statistically, significance 
was accepted at P <0.05. 
 
Results  
Laser dose effects on MCF-7 cell lines 
The effects of 532 nm laser irradiation on cell 
growth at different doses were tested using the 
Alamar Blue assay. The results of the untreated and 
irradiated cells were presented in (Fig. 2). The data 
obtained as a result of the percent reduction occurs in 
MCF-7 cancer cell viability tests were also 
demonstrated in (Table 2). Generally, it was proven 
that the cell proliferation rates were lower in the 
treatment groups than in the control groups. However, 
the lowest cell proliferation was detected in those cell 
irradiations with the highest power of 0.1 W 
significantly (P <0.001) at all exposure time with the 
lowest rate of cell viability (approximately 53 to 
63.5%) after 24 h incubation if compared to other 
laser power values. At the power of 0.002 W, the cells 
had a significantly increased (P <0.005) survival rate 
with 70.3% viability after 60 s exposure whereby the 
cell viability for the control (untreated) group had the 
highest percentage of 93.48%. Meanwhile, at the same 
time exposure of 60 s but at different power values 
(0.02, 0.06 and 0.1 W), the cell viability decreased 
significantly (P <0.001 to P <0.005) at 70.04% (25.07% 
reduction), 65.41% (30.03% reduction), and 64.04% 
(31.49% reduction), respectively. As the power of laser 
light increases, the more cells will reduce. 
In other case with the same power for 0.002, 0.02, 
0.06 and 0.1 W at 540 s exposure, the number of 
viability cells reduced significantly (P <0.001 to  
P <0.005) as shown in the graph with the viability 
percentage of 61.40% (32.08% reduction), 65.17% 
(28.31% reduction), 60.1% (33.38% reduction), and 
lastly 57.29% (36.19% reduction), respectively. The 
cell growth inhibition for 900 s exposure time for all 
power of 0.002, 0.02, 0.06, and 0.1 W had the 
following cell viability percentages: 63.22% (30.23% 
reduction), 63.61% (29.87% reduction), 62.02% 
(31.43% reduction), and finally is 52.88% (40.6% 
reduction). Based on the cell viability trend, cancer 
cell growth inhibition increased with higher laser 
 
 
Fig. 2 — The graph shows the percentage of cell viability of 
MCF-7 line, irradiated with a laser from 0.002 to 0.1 W at 60 s  
(1 min), 540 s (9 min) and 900 s (15 min) exposure time 
 
Table 2 — List of the% reduction for the cell treated with 
different power and time exposure 
Power (W)/ 
Exposure time  
60 s 540 s 900 s 
Reduction (%) Reduction (%) Reduction (%) 
0.002  24.79 ± 2.39 32.08 ± 1.89 30.23 ± 0.63 
0.02  25.07 ± 1.25 28.31 ± 4.58 29.87 ± 2.12 
0.06  30.03 ± 1.68  33.38 ± 4.46 31.43 ± 1.95  
0.1  31.49 ± 3.23 36.19 ± 2.73 40.60 ± 3.93 




power and long time exposure. It was evident that the 
highest cancer cell growth inhibition occurred at the 
maximum power (0.1 W) and the longest exposure 
time (900 s). A possible explanation for the low  
cell viability is hyperthermia effects experienced by 
the cells after being heated by the laser beam that 
caused a localised temperature exceeding 45°C  
at which cancer cells can be damaged while normal 
human cells remained alive
9,10
. Thermal energy  
was deposited in cancer tissue upon absorption of  
light released by laser and cancer tumours are much 
more heat-sensitive compared to healthy tissues 
because of the high acidity of the cancer cells as a 






The general result of this work was that laser 
irradiation caused a 25-40% reduction in MCF-7 cell 
proliferation which was below the desired 50% 
reduction. A probable reason for this relatively low% 
reduction was its multifactorial radio-resistance 
whereby the surviving cells could have acquired 
radio-resistance. Small populations of cancer cells 
might have survived after treatment and repopulated 
with advanced malignant phenotypes
30
. Cancer  
Stem Cells (CSCs) within tumours are one of  
the factors of radio-resistance and this property 
contributes to the poor therapeutic outcome of  
cancer patients
31
. This CSC harbour low reactive 
oxygen species (ROS) formed following irradiation 
which leading the reduction of DNA double strand 
breaks and expressing a high level of free radicals 
scavenger system. Free radical scavenger is an 




Furthermore, overproduction of MicroRNAs 
(miRNAs) might have been one of the reasons the 
MCF-7 survived after irradiation of low-level laser 
making them more resistant to the irradiation
33
. 
Numerous researches have shown that miRNAs could 
function as radiosensitizers to strengthen the 
radiosensitivity of cancer cells but unfortunately, it also 
can cause radio-resistance when overexpressed in cancer 
cells
34







 act as tumour 
radiosensitizers while miR-95
39
 is promoting tumour 
radio-resistance in breast cancer cells. However, the 
overexpression of miR-200c in MCF-7 cells increased 
the survival fraction in MCF-7 cells post-irradiation
36
. 
Another factor for the cell resistance to radiation 
was attributed to hypoxia that refers to oxygen 
deficiency in cancer cells. Cancer cells are known to 
provide insufficient oxygen because of their abnormal 
vasculature, which leads to severe hypoxia in tumour 
cells that are away from capillaries
40
. This hypoxic 
condition of cancer cells protects them from radiation 
making them to be two or three times more resistant 
to irradiation
41
. In contrast, cells will be sensitive to 
irradiation when they have enough oxygen supply 




By analyzing using the dose, the viability of cells 
that increased and decreased depending on the power 
and exposure time followed the biphasic-dose 
response that explained the cell behavior after laser 
irradiation. Inadequate power density or short 
exposure time may have no impact on the cell, but 
inhibitory effects will occur if too much power or 
long exposure time. There is an optimal relationship 
between power and exposure time that results in 
maximum stimulating action
42
. Based on the viability 
trend in (Fig. 2), the graph shows the linearly 
decreasing of viability trend as the doses increased. 
However, at 21.6 J/cm² (0.02 W, 540 s) the viability is 
higher than the cell treated with dose 2.16 J/cm² 
(0.002 W, 540 s). In addition, the same doses do not 
apply the same results. For example, at dose 108 
J/cm², the cell experienced more reduction as viability 
percent is 57.29% for 0.1 W, 540 s but not for  
0.06 W, 900 s with 62.02% of viable cells. Thus, the 
positive effect can be observed using high power  
with short exposure time which is safest to use in 
cancer therapy as the irradiation exposure duration 
reduced. The lowest exposure time is better to  
provide minimal undesired effect and offer less  
time-consuming during treatment which is 
comfortable to the patient. Overall, the result shows 
that at dose 180 J/cm² the cell viability of the MCF-7 
is the lowest, followed by 108 J/cm² compare to  
the other doses. This can be assumed that dose is not 
the key parameters to be tested, but the time of 
exposure and the power density used
3
. The cell will be 
inhibited differently by different times and power 
exposure. From the result, it reveals that high power 
with long exposure time increased laser cell bio-
inhibition. In addition, no major changes occurred in 
the results as the treatment were repeated for five 
times including trials to ensure the reproducibility of 
the experiment. 




The microscopic images of both untreated and 
treated MCF-7 cells are shown in (Fig. 3). Based on 
(Fig. 3A), the untreated MCF-7 cells maintained their 
original morphology and appear to be in close contact 
with each other even when the incubation was 
prolonged to 48 h. The shape for control cells without 
any treatment is an epithelial cell line. However,  
some cancer cells in (Fig. 3B-D) treated with laser 
irradiation have changed in shape into circular 
morphology in that the circular shape is an indicator of 
the dead cell
18
. Nevertheless, the small number of 
circular cells suggested that there was not much 
apoptosis and necrosis occurred in this work. But one 
thing is clear – increasing the laser power and 
lengthening the irradiation exposure time can cause 
higher cell growth inhibition. 
 
Conclusion 
In conclusion, MCF-7 breast cancer cell lines 
possessed appreciable resistance toward green laser 
irradiation set at low power up to 0.1 W as the cell 
viability not reduced by half of percentage. The  
532 nm laser irradiation slightly inhibit proliferation of 
MCF-7 cells at any doses in the range of 60 to 70% of 
cell viability compared to untreated cells which 
maintained their survival with 93% of viability. The 
data also showed that the highest cancer cell growth 
inhibition occurred at the maximum power (0.1 W) and 
the longest exposure time (900 s). Increasing the laser 
power strength and lengthening the irradiation time had 
a clear impact on inhibiting the MCF-7 cell proliferation 
and optimal laser parameter observed at high power 
with short exposure time.  
 
Acknowledgement 
The authors would like to thank the Malaysian 
government for the FRGS grant (203/PFIZIK/6711598) 
that made this work possible, the staff of Oncology and 
Radiological Cluster, Advanced Medical and Dental 
Institute (AMDI) for their assistance and support 
throughout this research activities. 
 
Conflict of interest 
All authors declare no conflict of interest. 
 
References  
1 World Health Organization, Latest global cancer data. 
International Agency for Research on Cancer, (2018) 13. 
2 Hecht J, A short history of laser development. Appl Opt, 49 
(2010) 99. 
3 Jawad M, Abdul Qader S, Zaidan A, Zaidan B, Naji A & 
Qader AI, An Overview of laser principle, Laser-Tissue 
interaction mechanisms and laser safety precautions for 
medical laser users. Int J Pharmacol, 7 (2011) 149. 
4 Ansari MA, Erfanzadeh M & Mohajerani E, Mechanisms of 
Laser-Tissue Interaction : II . Tissue Thermal Properties.  
J Lasers Med Sci, 4 (2013) 99. 
5 Jain K, Suryawanshi P & Chaudhari A, Recovery of acerbic 
anaerobic digester for biogas production from pomegranate 
shells using organic loading approach. Indian J Biochem 
Biophys, 57 (2020) 86. 
6 Dicello JF, Absorption Characteristics of protons and 
photons in tissue. Technol Cancer Res Treat, 6 (2014) 25. 
7 Abrahamse H& Hamblin MR, New photosensitizers for 
photodynamic therapy. J Biochem, 473 (2017) 347. 
8 Kohale BR, Agrawal AA, Sope AB, Pardeshi KV &  
Raut CP, Low-level laser therapy: A Literature review. Int  
J Laser Dent, 5 (2016) 1. 
9 Suriyanto, Ng EYK & Kumar SD, Physical mechanism and 
modeling of heat generation and transfer in magnetic fluid 
hyperthermia through Néelian and Brownian relaxation: a 
review. Biomed Eng Online, 16 (2017) 2. 
10 Tang F, Zhang Y, Zhang J, Guo J & Liu R, Assessment  
of the efficacy of laser hyperthermia and nanoparticle-
enhanced therapies by heat shock protein analysis. AIP Adv,  
4 (2014) 1. 
11 Habash RWY, Bansal R, Krewski D & Alhafid HT, Thermal 
therapy, Part III: Ablation techniques. Crit Rev Biomed Eng, 
35 (2007) 37. 
12 Avci P, Gupta A, Sadasivam M, Vecchio D, Pam Z, Pam N 
& Hamblin MR, Low-level laser (light) therapy (LLLT) in 
skin: Stimulating, healing, restoring. Semin Cutan Med Surg, 
32 (2013) 41. 
13 Bamps M, Dok R & Nuyts S, Low-level laser therapy 
stimulates proliferation in head and neck squamous cell 
carcinoma cells. Front Oncol, 8 (2018) 1. 
14 Gomes Henriques ÁC, Ginani F, Oliveira RM, Keesen TSL, 
Galvão BC, Augusto OR, Alexandre DC, Jurema FL,  
 
 
Fig. 3 — Image of MCF-7 Cell lines (A) Untreated cells (control); 
(B) The cells treated with 0.1 W for 15 min exposure; (C) The 
cells treated with 0.1 W for 9 min exposure; and (D) The cells 
treated with 0.1 W for 60 s exposure. Magnification was 40x 




Della CR & De Almeida FR, Low-level laser therapy 
promotes proliferation and invasion of oral squamous cell 
carcinoma cells. Lasers Med Sci, 29 (2014) 1385. 
15 Aparecida J, Chaves DA & Silva S, Effect of low-level laser 
therapy on the initial stages of tissue repair: basic principles. 
An Bras Dermatol, 86 (2011) 947. 
16 Hamblin MR, Photobiomodulation or low-level laser 
therapy. J Biophotonics, 9 (2016) 1122. 
17 Dima R, Francio VT, Towery C & Davani S, Review of 
literature on low-level laser therapy benefits for 
nonpharmacological pain control in chronic pain and 
osteoarthritis. J Chem Inf Model, 53 (2013) 1689. 
18 Kara C, Selamet H, Gökmenoğlu C & Kara N, Low level 
laser therapy induces increased viability and proliferation in 
isolated cancer cells. Cell Prolif, 51 (2018) 1. 
19 Dastanpour S, Beitollahi JM & Saber K, The Effect of Low-
Level Laser Therapy on Human Leukemic Cells. J Lasers 
Med Sci, 6 (2015) 74. 
20 Badruzzaman A, Bidin N, Pauliena S & Bohari M, The 
Effect of Laser Irradiation on The Survivability Rate of 
Different Type of Cells. Bul Opt, 2 (2016) 37. 
21 Sperandio FF, Giudice FS, Correa L, Decio J, Hamblin MR 
& Sousa S, Low-level laser therapy can produce increased 
aggressiveness of dysplastic and oral cancer cell lines  
by modulation of Akt/mTOR signaling pathway. Bone,  
23 (2013) 1. 
22 Zecha J, Raber-durlacher J, Nair R & Epstein J, Low-level 
laser therapy/photobiomodulation in the management of side 
effects of chemoradiation therapy in head and neck cancer: 
part 2: proposed applications and treatment protocols. 
Support Care Cancer, 24 (2017) 2793. 
23 Houreld NN, Shedding light on a new treatment for diabetic 
wound healing: A review on phototherapy. Sci World J,  
1 (2014) 1. 
24 Wang X, Tian F, Soni SS, Gonzalez-Lima F & Liu H, 
Interplay between up-regulation of cytochrome-c-oxidase 
and hemoglobin oxygenation induced by near-infrared laser. 
Sci Rep, 6 (2016) 1. 
25 Wang X, Tian F, Reddy DD, Soni SS, Gonzalez LF & Liu H, 
Up-regulation of cerebral cytochrome-c-oxidase and 
hemodynamics by transcranial infrared laser stimulation: A 
broadband near-infrared spectroscopy study. J Cereb Blood 
Flow Metab, 37 (2017) 3789. 
26 Selvam P, Vijayakumar T, Wadhwani Ashish & 
Muthulakshmi, L, Bioreduction of silver nanoparticles from 
aerial parts of Euphorbia hirta L. (EH-ET) and its potent 
anticancer activities against neuroblastoma cell lines. Indian 
J Biochem Biophys, 56 (2019) 132. 
27 Hamblin MR, Nelson ST & Strahan JR, Photobiomodulation 
and cancer: What is the truth? Photomed Laser Surg, 36 
(2018) 241. 
28 Chen CH, Hung HS & Hsu SH, Low-energy laser irradiation 
increases endothelial cell proliferation, migration, and enos 
gene expression possibly via PI3K signal pathway. Lasers 
Surg Med, 40 (2008) 46. 
29 Das U, Saha T & Das SK, Trianthema portulacastrum L. 
extract protects against gamma radiation induced human red 
blood cell membrane damage in vitro. Indian J Biochem 
Biophys, 55 (2018) 321. 
30 Wu TS, Lin BR & Chang HH, Radio resistance mechanisms 
of cancers: An overview and future perspectives. Biol Med, 2 
(2015) 1. 
31 Peitzsch C, Kurth I, Kunz-Schughart L, Baumann M & 
Dubrovska A, Discovery of the cancer stem cell related 
determinants of radioresistance. Radiother Oncol, 108  
(2013) 378. 
32 Lagadec C, Dekmezian C, Bauché L & Pajonk F, Oxygen 
levels do not determine radiation survival of breast cancer 
stem cells. PLoS One, 7 (2012) 1. 
33 Zhang Y, Xu B & Zhang XP, Effects of miRNAs on 
functions of breast cancer stem cells and treatment of breast 
cancer. Onco Targets Ther, 11 (2018) 4263. 
34 Zhang L, Wang C & Xue ZX, Inhibition of miR-630 
enhances the cell resistance to radiation by directly  
targeting CDC14A in human glioma. Am J Transl Res, 9 
(2017) 1255. 
35 Yang ZX, Sun YH, He JG, Cao H & Jiang GQ, Increased 
activity of CHK enhances the radioresistance of MCF-7 
breast cancer stem cells. Oncol Lett, 10 (2015) 3443. 
36 Sun Q, Liu T, Yuan Y & Guo Z, MiR-200c inhibits 
autophagy and enhances radiosensitivity in breast cancer 
cells by targeting UBQLN1. Int J Cancer, 136 (2015) 1003. 
37 Gasparini P, Lovat F, Fassan M & Casadei L, Protective role 
of miR-155 in breast cancer through RAD51 targeting 
impairs homologous recombination after irradiation. Proc 
Natl Acad Sci U S A, 111 (2014) 4536. 
38 Srivastava S & Pandey A, Computational screening of 
anticancer drugs targeting miRNA155 synthesis in breast 
cancer. Indian J Biochem Biophys, 57 (2020) 389. 
39 Huang X, Taeb S & Jahangiri S, miRNA-95 Mediates 
Radioresistance in tumors by targeting the sphingolipid 
phosphatase SGPP1. Cancer Res, 73 (2013) 6972. 
40 Muz B, Puente P de la, Azab F & Azab AK, The role of 
hypoxia in cancer progression, angiogenesis, metastasis, and 
resistance to therapy. Dove Press J Hypoxia, 3 (2015) 83. 
41 Luzhna L, Filkowski J & Kovalchuk O, High and low dose 
radiation effects on mammary adenocarcinoma cells – An 
epigenetic connection. Oncol Sci, 3 (2016) 3. 
42 Huang YY, Sharma SK, Carroll J & Hamblin MR, Biphasic 
dose response in low level light therapy - an update. Dose-
Response, 9 (2011) 602. 
 
